In summary, biologics improved clinical symptoms, nasal polyp scores, olfaction, and quality of life in ENT conditions, particularly CRSwNP and allergic rhinitis, with favorable safety profiles and additional benefits, including reduced need for surgery and lower IgE levels. This evidence concerns the gene IGHE and allergic rhinitis.